GRANT | DATE | AMOUNT | PROGRAM |
---|---|---|---|
Aalborg University
Molecular Prediction of Crohn's Disease Using Network Analysis of Multi-Omics Data in Prediagnostic Samples |
05.20.2025 | $5,598,971.00 | Crohn's Disease, Prevention |
The University of Chicago
Characterization and longitudinal evaluation of subclinical perianal fistulizing Crohn's disease (pCD) |
05.20.2025 | $1,205,948.00 | Crohn's Disease, Diagnostics |
St. Mark's Hospital Foundation
Perianal Crohn's Disease (pCD) Educational Meeting and TOpCLASS Consortium Member Conference |
02.18.2025 | $164,712.00 | Crohn's Disease, Diagnostics |
Children's Hospital Medical Center
Validation of a Peripheral Blood Biomarker Signature for Anti-TNF Response in Patients with Crohn's Disease (ATPBioS) |
02.03.2025 | $1,876,476.00 | Crohn's Disease, Diagnostics |
Icahn School Of Medicine At Mount Sinai
The REFLECTION Study: Predicting Outcomes Following Ileocecal Resection in Crohn's Disease. |
01.22.2025 | $1,902,602.00 | Crohn's Disease, Prevention |
St. Mark's Hospital Foundation
Global Perianal Crohn's Disease Priority Setting Partnership |
01.09.2025 | $24,288.00 | Crohn's Disease, Diagnostics |
Crohn's & Colitis Foundation, Inc.
Achieving Remission in IBD: Optimizing Treat-to-Target in Clinical Practice |
01.09.2025 | $3,994,810.00 | Crohn's Disease, Disease Management |
Icahn School Of Medicine At Mount Sinai
Development of Novel LRRK2 Inhibitors to Treat Crohn's Disease |
01.09.2025 | $1,167,761.00 | Crohn's Disease, Therapeutics |
Icahn School Of Medicine At Mount Sinai
The Use of GLP-1R Agonists to Promote Epithelial Healing in Crohn's Disease |
11.05.2024 | $3,035,566.00 | Crohn's Disease, Therapeutics |
Alimentiv Inc.
Validation of the PRO Symptoms and Impacts Questionnaire for Crohn's Disease |
11.05.2024 | $1,275,257.00 | Crohn's Disease, Diagnostics |
Crohn's and Colitis UK
Implementation of a Lower GI Diagnostic Pathway in Primary Healthcare and development and dissemination of a Lower GI Patient Toolkit |
11.05.2024 | $638,508.00 | Crohn's Disease, Disease Management |
Mass General Brigham for the Brigham and Women's Hospital
Real-time Post-op Touchless, Remote Monitoring in Crohn's disease: The Sapphire Trial |
10.22.2024 | $5,117,928.00 | Crohn's Disease, Disease Management |
The Chancellor, Masters and Scholars of the University of Cambridge
New insights into Crohn's disease from studying Naked Mole Rats |
10.22.2024 | $1,857,860.00 | Crohn's Disease, Disease Biology |
Mass General Brigham for the Massachusetts General Hospital
Validation of Wireless Thermal and Microscopic Imaging Technology for Quantifying Inflammation and Fibrosis in Crohn's Disease |
10.22.2024 | $3,057,197.00 | Crohn's Disease, Diagnostics |
Crohn's & Colitis Foundation, Inc.
Sponsorship for the 2025 Crohn's & Colitis Congress presented by The Crohn's & Colitis Foundation and the American Gastroenterological Association |
10.22.2024 | $235,000.00 | Crohn's Disease, Disease Management |
Katholieke Universiteit te Leuven
Targeting chronic inflammation and tissue remodelling in Crohn's disease with engineered T cells |
10.22.2024 | $815,615.00 | Crohn's Disease, Disease Biology |
Board of Trustees of the Leland Stanford Junior University
Determining the Therapeutic Potential of Statins on Stricturing Crohn's Disease |
10.09.2024 | $2,034,990.00 | Crohn's Disease, Therapeutics |
The University of Edinburgh
Building a cross-discipline scientific approach towards understanding Crohn's disease - Leveraging UK Helmsley Studies |
09.24.2024 | $47,977.00 | Crohn's Disease, Diagnostics |
The Governors of the University of Calgary
A Drug-Wide Scan to Identify Repurposed Medications for Crohn's Disease |
09.24.2024 | $1,248,808.00 | Crohn's Disease, Therapeutics |
University of Glasgow Court
Title: Unraveling the role of the gut microbiome in postoperative outcomes and disease recurrence in surgical adults with Crohn's disease treated with exclusive enteral nutrition. The MI-OCEAN study |
09.10.2024 | $3,187,027.00 | Crohn's Disease, Prevention |
Prev
12...15
Next
1 - 20 of 293 results
|